AAAAAA

   
Results: 1-8 |
Results: 8
OSTEOBLASTS SECRETE INOSITOL PHOSPHOGLYCANS, NOVEL MEDIATORS OF BONE-RESORPTION
Authors: EVANS CE GALASKO GTF BURKE T WARD C GALASKO CSB
Citation: Ce. Evans et al., OSTEOBLASTS SECRETE INOSITOL PHOSPHOGLYCANS, NOVEL MEDIATORS OF BONE-RESORPTION, Journal of bone and mineral research, 13(9), 1998, pp. 7-7
ARE IPGS AUTOCRINE MODULATORS OF HUMAN OSTEOBLAST-LIKE CELLS
Authors: EVANS CE GALASKO GTF BURKE T WARD C GALASKO CSB
Citation: Ce. Evans et al., ARE IPGS AUTOCRINE MODULATORS OF HUMAN OSTEOBLAST-LIKE CELLS, Journal of bone and mineral research, 13(9), 1998, pp. 12-12
IPGS AS SIGNALING FACTORS IN BONE REMODELING
Authors: GALASKO GTF BURKE T EVANS CE WARD C GALASKO CSB
Citation: Gtf. Galasko et al., IPGS AS SIGNALING FACTORS IN BONE REMODELING, Journal of dental research, 77, 1998, pp. 858-858
THE NOVEL INOSITOLPHOSPHOGLYCAN INSULIN ANTAGONIST, FRACTION V-3, INHIBITS INSULIN STIMULATION OF GLYCOGEN-SYNTHESIS IN MUSCLE IN-VIVO
Authors: GALASKO GTF GANZ JR GUILBEAULT D
Citation: Gtf. Galasko et al., THE NOVEL INOSITOLPHOSPHOGLYCAN INSULIN ANTAGONIST, FRACTION V-3, INHIBITS INSULIN STIMULATION OF GLYCOGEN-SYNTHESIS IN MUSCLE IN-VIVO, Diabetes, 47, 1998, pp. 1682-1682
SIGNALING FACTORS IN BONE METABOLISM
Authors: GALASKO GTF BURKE TJ BURLEY EV OSAEDOH D EVANS CE GALASKO CSB
Citation: Gtf. Galasko et al., SIGNALING FACTORS IN BONE METABOLISM, Journal of dental research, 76, 1997, pp. 2614-2614
EFFECTS OF THE INSULIN ANTAGONIST, FRACTION V-3, ON OSTEOBLAST GROWTH
Authors: GALASKO GTF EVANS CE WARD SR GALASKO CSB
Citation: Gtf. Galasko et al., EFFECTS OF THE INSULIN ANTAGONIST, FRACTION V-3, ON OSTEOBLAST GROWTH, Journal of dental research, 75, 1996, pp. 3109-3109
CIRCULATING FACTORS AND INSULIN-RESISTANCE .2. THE ACTION OF THE NOVEL MYOINOSITOL CYCLIC 1,2-INOSITOL PHOSPHATE PHOSPHOGLYCAN INSULIN ANTAGONIST FROM HUMAN PLASMA IN REGULATING PYRUVATE-DEHYDROGENASE PHOSPHATASE
Authors: GALASKO GTF ABE S LILLEY K ZHANG CG LARNER J
Citation: Gtf. Galasko et al., CIRCULATING FACTORS AND INSULIN-RESISTANCE .2. THE ACTION OF THE NOVEL MYOINOSITOL CYCLIC 1,2-INOSITOL PHOSPHATE PHOSPHOGLYCAN INSULIN ANTAGONIST FROM HUMAN PLASMA IN REGULATING PYRUVATE-DEHYDROGENASE PHOSPHATASE, The Journal of clinical endocrinology and metabolism, 81(3), 1996, pp. 1051-1057
CIRCULATING FACTORS AND INSULIN-RESISTANCE .1. A NOVEL MYOINOSITOL 1,2-CYCLIC PHOSPHATE PHOSPHOGLYCAN INSULIN ANTAGONIST FROM HUMAN PLASMA IS ELEVATED IN NONINSULIN-DEPENDENT DIABETES-MELLITUS
Authors: GALASKO GTF BAO YD BROOMFIELD SJ HOOPER NM TURNER AJ LARNER J
Citation: Gtf. Galasko et al., CIRCULATING FACTORS AND INSULIN-RESISTANCE .1. A NOVEL MYOINOSITOL 1,2-CYCLIC PHOSPHATE PHOSPHOGLYCAN INSULIN ANTAGONIST FROM HUMAN PLASMA IS ELEVATED IN NONINSULIN-DEPENDENT DIABETES-MELLITUS, The Journal of clinical endocrinology and metabolism, 80(8), 1995, pp. 2419-2429
Risultati: 1-8 |